Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theo de Witte

Showing results (41-50 of 151) with videos related to

Pageof 16
Sort By:
Human Gene Therapy|March 28, 2003
Monitoring of developing graft-versus-host disease mediated by herpes simplex virus thymidine kinase gene-transduced T cellsSebastianus Kolen, Mo Weijtens, Anton Hagenbeek, et al.
Haematologica|October 26, 2010
Efficacy and outcome of autologous transplantation in rare myelomasCurly Morris, Mary Drake, Jane Apperley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2009
Higher incidence of relapse with peripheral blood rather than marrow as a source of stem cells in adults with acute myelocytic leukemia autografted during the first remissionNorbert-Claude Gorin, Myriam Labopin, Didier Blaise, et al.
British Journal of Haematology|November 17, 2009
Unrelated stem cell transplantation after reduced intensity conditioning for patients with multiple myeloma relapsing after autologous transplantationNicolaus Kröger, Avichai Shimoni, Georgia Schilling, et al.
Blood|July 25, 2007
Gfi1 ubiquitination and proteasomal degradation is inhibited by the ubiquitin ligase Triad1Jurgen A F Marteijn, Laurens T van der Meer, Liesbeth van Emst, et al.
Cancer Immunology, Immunotherapy : CII|June 4, 2013
Immunogenicity of dendritic cells pulsed with MAGE3, Survivin and B-cell maturation antigen mRNA for vaccination of multiple myeloma patientsWillemijn Hobo, Leonie Strobbe, Frans Maas, et al.
Blood|August 25, 2005
The E3 ubiquitin-protein ligase Triad1 inhibits clonogenic growth of primary myeloid progenitor cellsJurgen A F Marteijn, Liesbeth van Emst, Claudia A J Erpelinck-Verschueren, et al.
Plos One|July 9, 2011
A polymorphism in the splice donor site of ZNF419 results in the novel renal cell carcinoma-associated minor histocompatibility antigen ZAPHIRKelly Broen, Henriette Levenga, Johanna Vos, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 9, 2013
Allogeneic stem cell transplantation for myelofibrosis with leukemic transformation: a study from the Myeloproliferative Neoplasm Subcommittee of the CMWP of the European Group for Blood and Marrow TransplantationHaefaa Alchalby, Tatjana Zabelina, Thomas Stübig, et al.
British Journal of Haematology|September 15, 2005
Expression of C-IAP1, C-IAP2 and SURVIVIN discriminates different types of lymphoid malignanciesAniek O de Graaf, J Han van Krieken, Evelyn Tönnissen, et al.
Pageof 16

Showing results (41-50 of 151) with videos related to

Sort By:
Pageof 16
Human Gene Therapy|March 28, 2003
Monitoring of developing graft-versus-host disease mediated by herpes simplex virus thymidine kinase gene-transduced T cellsSebastianus Kolen, Mo Weijtens, Anton Hagenbeek, et al.
Haematologica|October 26, 2010
Efficacy and outcome of autologous transplantation in rare myelomasCurly Morris, Mary Drake, Jane Apperley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2009
Higher incidence of relapse with peripheral blood rather than marrow as a source of stem cells in adults with acute myelocytic leukemia autografted during the first remissionNorbert-Claude Gorin, Myriam Labopin, Didier Blaise, et al.
British Journal of Haematology|November 17, 2009
Unrelated stem cell transplantation after reduced intensity conditioning for patients with multiple myeloma relapsing after autologous transplantationNicolaus Kröger, Avichai Shimoni, Georgia Schilling, et al.
Blood|July 25, 2007
Gfi1 ubiquitination and proteasomal degradation is inhibited by the ubiquitin ligase Triad1Jurgen A F Marteijn, Laurens T van der Meer, Liesbeth van Emst, et al.
Cancer Immunology, Immunotherapy : CII|June 4, 2013
Immunogenicity of dendritic cells pulsed with MAGE3, Survivin and B-cell maturation antigen mRNA for vaccination of multiple myeloma patientsWillemijn Hobo, Leonie Strobbe, Frans Maas, et al.
Blood|August 25, 2005
The E3 ubiquitin-protein ligase Triad1 inhibits clonogenic growth of primary myeloid progenitor cellsJurgen A F Marteijn, Liesbeth van Emst, Claudia A J Erpelinck-Verschueren, et al.
Plos One|July 9, 2011
A polymorphism in the splice donor site of ZNF419 results in the novel renal cell carcinoma-associated minor histocompatibility antigen ZAPHIRKelly Broen, Henriette Levenga, Johanna Vos, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 9, 2013
Allogeneic stem cell transplantation for myelofibrosis with leukemic transformation: a study from the Myeloproliferative Neoplasm Subcommittee of the CMWP of the European Group for Blood and Marrow TransplantationHaefaa Alchalby, Tatjana Zabelina, Thomas Stübig, et al.
British Journal of Haematology|September 15, 2005
Expression of C-IAP1, C-IAP2 and SURVIVIN discriminates different types of lymphoid malignanciesAniek O de Graaf, J Han van Krieken, Evelyn Tönnissen, et al.
Pageof 16